“Roflumilast Cream 0.3% in Patients With Chronic Plaque Psoriasis: Individual Patient PASI and PASI-HD Responses: Pooled DERMIS-1 and DERMIS-2 Phase 3 Trials”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 2, Mar. 2024, p. s355, https://doi.org/10.25251/skin.8.supp.355.